New research shows that blood pressure medications do not increase the risk of COVID-19

New research shows that blood pressure medications do not increase the risk of COVID-19

Three major studies on Friday found that commonly used blood pressure medications did not increase the risk of COVID-19 infection or increase the risk of serious illness. Positive news for them.

Three major studies on Friday found that commonly used hypertension medications did not increase the risk of COVID-19. infection or serious illness. Positive news for them

ACE inhibitors include Rampril, Lacinopril, and other drug options that will expire in April. RBI, on the other hand, includes waltz and lasartan, and usually ends in cancer.

Animal studies have raised concerns that the drugs could increase the levels of a protein called ACE2 in the body, which could lead to coronavirus attacks on human cells.

Animal conflict studies have also shown that having too much ACE2 protein can reduce the inflammatory response in the lungs, which is beneficial.


All three new findings are published in the New England Journal of Medicine (NEJM).

Each one examined the records of thousands of people, whether they had a pill, whether they had an infection and how the disease was spread.

They then used statistical methods to control other causes, such as the underlying health condition that can lead to infection and serious CoVID-19.

Reynolds, who studied about 12,600 people at the NYU Grossman School of Medicine, told AFP: ACE inhibitors and angiotensin receptor blockers. There was no difference in the house for the positive test

The studies were "observers", meaning the researchers looked at the effects of a risk factor..

This type of research is always considered weaker than "experimental", which involves control and intervention, leaving little room for opportunity.

NEJM's editorial staff acknowledged this hereditary limitation, but added: "Studies in three populations and different designs in different populations must deliver a strong message."

Reynolds said the results were "surprising" because he was concerned about patients who had read the press report and asked if they wanted to stop using octic drugs."I'm really grateful she was released and thank those who worked hard for her release, and we're glad she's alive."

Answering another important question, said Mandeep Mehram, Medical Director, Brahm & Women's Hospital (BWH) Cardi Vascular Center, who conducted another study.

As the epidemic began, when it became clear that people with heart disease were at risk of severe COVID-19, scientists wondered: was it a heart disease that was a risk factor or a medication? Used to overcome it?

He said the new debate resolves research in favor of the former.

"It is beyond doubt that CoVID-19 somehow interacts with the cardiovascular system," Mehram said.

Potential benefits? A Mehra study, which looked at 9,000 patients in 11 countries, also linked the use of blood pressure medications to a lower risk of dying from COVID-19.

It is unknown at this time what he meant by "drugs." "It's not clear why this happened - it helped the heart of the drug, which in turn helped determine the effect of the bacteria." And are working

( Hamari News )